Finance

Lists
CELC:NASDAQ
Celcuity Inc
$65.25
-0.49%
(-0.32) 1D
$63.20
-3.14% (-2.05)
After hours
Closed: Oct 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CELC...
Open
$65.57
High
$66.30
Low
$63.49
Mkt. cap
3.19B
Avg. vol.
1.58M
Volume
1.32M
52-wk high
$151.02
52-wk low
$53.54
EPS
-$4.30
Beta
0.10
Shares outstanding
48.93M
No. of employees
155
Open
$65.57
High
$66.30
Low
$63.49
Mkt. cap
3.19B
Avg. vol.
1.58M
Volume
1.32M
52-wk high
$151.02
52-wk low
$53.54
EPS
-$4.30
Beta
0.10
Shares outstanding
48.93M
No. of employees
155
News stories
From web sources and news partners
About Celcuity Inc
CEO-
Employees155
Founded2011
HeadquartersMinneapolis, Minnesota, United States
SectorBiotechnology
Websitecelcuity.com
Analyst ratings
Based on 11 analysts giving stock ratings to CELC in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for CELC in the last 3 months.
Highest
Current $65.25
$175.00 (+168.20%)
Average
$155.18 (+137.82%)
Lowest
$134.00 (+105.36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tara Bancroft
TD Cowen
Buy
Maintained
$145.00
+122.2%
10/21/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$140.00
+114.6%
10/22/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$155.00
+137.5%
10/01/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
$147.00
+125.3%
10/02/2026
Gil Blum
Needham
Buy
Maintained
$134.00
+105.4%
09/30/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
$157.00
+140.6%
09/17/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
$173.00
+165.1%
08/18/2026
Bradley Canino
Guggenheim
Buy
Reiterated
$175.00
+168.2%
08/16/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
$165.00
+152.9%
08/14/2026
Stephen Willey
Stifel Nicolaus
Buy
Maintained
$150.00
+129.9%
08/14/2026
Eva Fortea Verdejo
Wells Fargo
Buy
Maintained
$166.00
+154.4%
08/14/2026
Silvan Turkcan
Citizens JMP
Buy
Maintained
$177.00
+171.3%
07/15/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
$150.00
+129.9%
04/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
34.92M
37.31M
33.06M
31.08M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.93M
11.89M
17.44M
35.04M
Operating expense
42.85M
49.20M
50.51M
66.12M
Total operating expenses
42.85M
49.20M
50.51M
66.12M
Operating income
-42.85M
-49.20M
-50.51M
-66.12M
Other non operating income
-
-
-
-
EBT including unusual items
-43.80M
-50.97M
-52.84M
-78.86M
EBT excluding unusual items
-43.80M
-50.97M
-52.84M
-67.39M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-43.80M
-50.97M
-52.84M
-78.86M
Net profit margin
-
-
-
-
Earnings per share
-0.78
-0.73
-0.86
-1.07
Interest and investment income
3.64M
4.39M
3.75M
4.15M
Interest expense
-4.60M
-6.17M
-6.08M
-5.42M
Net interest expenses
-955.00K
-1.77M
-2.33M
-1.27M
Depreciation and amortization charges
-
-
-
-
EBITDA
-42.81M
-49.15M
-50.46M
-66.06M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps